doi: 10.1016/0014-2999(76)90094-7.
Behavioural effects of a new non-phenylethylamine anorexigenic agent: mazindol
- PMID: 945167
- DOI: 10.1016/0014-2999(76)90094-7
Item in Clipboard
Behavioural effects of a new non-phenylethylamine anorexigenic agent: mazindol
Eur J Pharmacol.
1976 Apr.
Abstract
Mazindol, a new anorexigenic agent which possesses a different chemical structure from phenylethylamine derivatives such as amphetamine, causes anorexia along with increases in locomotor activity and body temperature. Mazindol also induces stereotyped behaviour and, if injected into rats with unilateral nigro-striatal lesions, causes turning towards the lesioned side. Mazindol-induced anorexia is antagonized by pretreatment with alpha-methyl-p-tyrosine or pimozide. Pimozide pretreatment prevents the rotation induced by Mazindol in rats with unilateral nigro-striatal lesions. The involvement of dopamine in the mechanism whereby Mazindol elicits anorexia and turning behaviour is discussed.
Similar articles
-
Anorexic and behavioural effects of a new imidazo-isoindole derivative (mazindol) in comparison with d-amphetamine in the rat.Pharmacology. 1977;15(1):46-56. doi: 10.1159/000136662. Pharmacology. 1977. PMID: 557207
-
Mazindol anorexia is mediated by activation of dopaminergic mechanisms.Br J Pharmacol. 1976 Nov;58(3):367-72. Br J Pharmacol. 1976. PMID: 990591 Free PMC article.
-
Effects of mazindol, a non-phenylethylamine anorexigenic agent, on biogenic amine levels and turnover rate.Br J Pharmacol. 1976 Apr;56(4):431-6. doi: 10.1111/j.1476-5381.1976.tb07454.x. Br J Pharmacol. 1976. PMID: 1260223 Free PMC article.
-
[Behavioral changes induced by repeated administration of mazindol, an anorexiant, in rats].Nihon Shinkei Seishin Yakurigaku Zasshi. 1996 Aug;16(4):139-43. Nihon Shinkei Seishin Yakurigaku Zasshi. 1996. PMID: 8905803 Japanese.
-
Unexpected differences between mazindol and its homologs on biochemical and behavioral responses.J Pharmacol Exp Ther. 1981 Jun;217(3):745-9. J Pharmacol Exp Ther. 1981. PMID: 7194909
Cited by
-
Repeated administration of mazindol reduces spontaneous pain-related behaviors without modifying bone density and microarchitecture in a mouse model of complete Freund's adjuvant-induced knee arthritis.J Pain Res. 2017 Jul 27;10:1777-1786. doi: 10.2147/JPR.S136581. eCollection 2017. J Pain Res. 2017. PMID: 28794657 Free PMC article.
-
Fluoxetine at anorectic doses does not have properties of a dopamine uptake inhibitor.J Neural Transm Gen Sect. 1994;96(3):165-77. doi: 10.1007/BF01294784. J Neural Transm Gen Sect. 1994. PMID: 7826568
-
Food-intake and locomotor activity: effects of mazindol and spiperone [proceedings].Br J Pharmacol. 1978 Jun;63(2):412P-413P. Br J Pharmacol. 1978. PMID: 667485 Free PMC article. No abstract available.
-
Mazindol and amphetamine as inhibitors of the uptake and releasers of 3H-dopamine by rat striatal synaptosomes.Naunyn Schmiedebergs Arch Pharmacol. 1977 May;298(1):1-5. doi: 10.1007/BF00510979. Naunyn Schmiedebergs Arch Pharmacol. 1977. PMID: 882144
-
Effect of mazindol on brain dopamine turnover in spiperone-treated rats.J Neural Transm. 1979;44(1-2):13-9. doi: 10.1007/BF01252698. J Neural Transm. 1979. PMID: 438800
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
